J.-Y. M, A. M. O  B. A. E. Prevalence and Turnover of Peptidylglycine -amidating Monooxygenase mRNA in Atrial Cardiomyocytes. Journal of Molecular and Cellular Cardiology (1996) 28, 155-163. Peptidylglycine -amidating monooxygenase (PAM), the enzyme responsible for the -amidation of neuroendocrine peptides, is more prevalent in the atrium of the heart than in pituitary or brain. RNase protection assays indicate that PAM transcripts account for approximately 0.5% of the mRNA in the neonatal atrium and 0.06% of the mRNA in the neonatal ventricle. In primary atrial cardiomyocyte cultures PAM mRNA turns over slowly, with a half-life of approximately 20 h. Levels of PAM mRNA in primary atrial cardiomyocytes are increased to 165% of control upon treatment with dexamethasone and decreased to 63% of control upon treatment with thyroid hormone.
Introduction
atrium (Bloomquist et al., 1991; Zheng at al., 1994) . Atrial myocytes contain large dense core granules whose morphology closely resembles that of the In contrast, levels of the peptide amidating enzyme, peptidylglycine -amidating monooxygenase large dense core granules found in neurons and endocrine cells (DeBold et al., 1991; Rosenzweig (PAM) , are higher in atrium than in any other tissue examined (Braas et al., 1989; Maltese and Eipper, and Seidman, 1991) . While the large dense core granules of neurons and endocrine cells contain 1992; Lew and Smith, 1993) . Although endoproteolytically processed forms of PAM are stored mature peptide products derived from endogenous prohormones, the granules in atrial myocytes conin the large dense core granules of neurons and endocrine cells, uncleaved integral membrane PAM tain primarily unprocessed prohormone and endoproteolytic cleavage occures at or near the time proteins predominate in atrium and ventricle (Eipper et al., 1992; Maltese and Eipper, 1993 ; Oyarce and of secretion (Glembotski et al., 1990; Rosenzweig and Seidman, 1991; Greenwald et al., 1992; Sei et Eipper, 1993) . As for pro-ANP, endoproteolytic cleavage of PAM occurs at or near the time of seal., 1992) . Prohormone convertases 1 and 2, the subtilisin-like endoproteases thought to play a key cretion (Glembotski et al., 1990; Rosenzweig and Seidman, 1991; Maltese and Eipper, 1993) . role in prohormone cleavage in neurons and en-Although pro-ANP is not processed into -amtreating cultures with 10  cytosine--D-arabinofuranoside for 24 h. On the second day of idated product peptides, atrial granules contain precursors to enkephalin, thyrotropin releasing horculture, cells were placed into complete serum-free medium [DMEM-F12, 10 g/ml insulin, 5 g/ml mone (TRH), neuropeptide Y, adrenomedullin and dynorphin, each of which can be processed to yield transferrin, 1×10
−8
 NaSeO 3 , 1 mg/ml bovine serum albumin (fatty acid-free), 1×10 −9
 tri--amidated product peptides (Howells et al., 1986; Springhorn and Claycomb, 1989; Low et al., 1990;  iodothyronine, 1 n dexamethasone (American Reagent), 15 m HEPES, pH 7.4] containing 2  Marek and Mains, 1990; Carnell et al., 1992; Sakata et al., 1993; Ichiki et al., 1994; Ventura et al., 1994) .
cytosine--D-arabinofuranoside. Cells were subsequently maintained in this serum-free medium Metabolic labeling studies demonstrated that PAM accounts for 0.3 to 0.5% of the total protein synlacking cytosine--D-arabinofuranoside. For treatment of atrial cardiomyocytes with triiodothyronine thesis in primary cultures of neonatal atrial cardiomyocytes (Maltese and Eipper, 1993) . The or dexamethasone, cultures were fed with serumfree medium lacking both hormones on day 6 of expression of PAM in the heart shows developmental regulation, with striking changes in culture. After 48 h in complete serum-free medium lacking triiodothyronine and dexamethasone, culatrial and ventricular levels of PAM in the perinatal period (Ouafik et al., 1989) . PAM expression in tures were fed with serum free medium containing various concentrations of triiodothyronine or dexacultures of atrial cardiomyocytes is responsive to glucocorticoids and cAMP (Thiele et al., 1989) .
methasone; in general, cultures were analysed 48 h after hormone treatment. Unless indicated otherIn some tissues levels of PAM transcript are rapidly modulated. For example, in hippocampal wise, chemicals for cell culture were obtained from Sigma Chemical Co. (St. Louis, MO, USA). dentate granule neurons, levels of PAM transcript peak within 1 to 4 h following a single electroconvulsive treatment and return to baseline within 24 h (Bhat et al., 1993) . The forms of PAM Northern blot analysis transcript present in the atrium and ventricle change rapidly near the time of birth (Ouafik et al.,
Total RNA was extracted, fractionated on 1% agarose gels containing 2.2  formaldehyde and trans-1989). These rapid alterations in the level or form of PAM mRNA suggest the occurrence of rapid ferred to nylon membranes as described (Ouafik et al., 1990) . The SDS-PIPES buffer system changes in gene transcription and/or mRNA stability. The mechanisms underlying these changes (Bloomquist et al., 1991) was used with prehybridization for 30 min at 65°C and hybridization in mRNA level have not yet been investigated; the promoter for rat PAM is GC-rich and lacks a TATA overnight at 65°C with 1 to 2×10 6 cpm/ml cDNA probe (labeled with [ 32 P]-dCTP by random priming) motif (Hand et al., 1994) . In this series of studies we used an RNase protection assay to determine (Prime-It kit; Stratgene). Filters were washed twice with 5% SDS/1×SSC for 15 min at 65°C and the prevalence of PAM mRNA in neonatal atrium and ventricle, determine the half-life of PAM mRNA exposed to X-OMAT film (Kodak) for 1 to 4 h. For detection of all forms of PAM mRNA, the 1.3 kb in primary cultures of atrial cardiomyocytes and examine the effect of thyroid hormone and gluPst1/BamH1 fragment of rPAM-1 was used (bp 356-1682) (Ouafik et al., 1990) . cocorticoid treatment on expression of PAM mRNA in these cells.
Levels of the mRNA for ribosomal protein S26 are relatively invariant amongst tissues (Vincent et al., 1993) ; therefore PAM signals were normalized to the amount of S26 mRNA on each blot. A cDNA probe for rat S26 cDNA was generated using
Materials and Methods
oligonculeotide primers (25-mers) to amplify a fragment from cDNA prepared from adult rat atrial Preparation of cardiocyte cell cultures RNA; the 354 bp fragment (nt 37 to nt 390) was subcloned into pBluescript (SK minus) and detected Atrial tissue taken from 40 neonatal rats (SpragueDawley) on the day of birth (postnatal day 1) was the expected 0.7 kb mRNA on Northern blots. To quantify signals, autoradiograms were densitized dissociated using trypsin and collagenase (DeBold et al., 1991 bridization buffer, heat denatured for 5 min at 85°C and hybridized at 44°C overnight. RNase digestion 1991) were used to determine the half-life of PAM mRNA in primary cultures of neonatal atrial carwas performed at 37°C for 30 min after adding 200 l RNase mix (2.5 unit RNase A/ml, 100 units diomyocytes. 5,6-Dichloro-1--ribofuranosyl benzimidazole (DRB), an inhibitor of RNA polymerase RNase T1/ml) to the hybridization mix. Protected fragments were precipitated with 300 l Ambion II, was solubilized in serum-free medium (350 ) by agitation at 37°C for 3 h. The effect of 70  precipitation buffer, quickly washed with 75% cold ethanol and air-dried. RNA was resuspended in DRB on synthesis of poly(A+) RNA in these primary cultures was verified in preliminary experiments.
10 l gel-loading buffer, heat denatured at 85°C for 5 min and fractionated on a 3 or 5% acrylamide After 7 days in culture, cells were exposed to serumfree medium containing 70  DRB (Harrold et al., gel containing 8  urea. Gels were dried at 80°C under vacuum and exposed to film for 4 to 12 h 1991) for periods of time ranging from 4 to 48 h. After 24 h of exposure to DRB, cellular morphology and analysed using the Phosphorimager. Sizes were determined by comparison to samples of pBR322 remained normal; 48 h of exposure to DRB resulted in vacuolized, unhealthy looking cells, precluding digested with Msp I (New England BioLabs) and endlabeled with [
32 P]-dCTP using the Klenow enzyme the use of even higher concentrations of DRB (Messina, 1989; Marshall et al., 1991) . Equal amounts (Boehringer, Germany) for 15 min at 30°C. PAM mRNA levals were measured using riboof total RNA were obtained from control cultures and from cultures treated with DRB for 24 h. Total probes synthesized from two different fragments of PAM-1 cDNA. The Ant3 probe includes bp 438-RNA prepared from DRB-treated cultures was subjected to Northern blot analysis. The 1.3 kb Pst1/ 822 of rPAM-1 and was derived by EcoRV digestion of a short cDNA clone isolated when screening a BamH1 fragment of rPAM-1 (bp 356-1682) was used to detect all forms of PAM mRNA. DenSprague-Dawley rat anterior pituitary library; this probe recognizes all forms of rPAM mRNA. The sitometric analyses were performed as described above. In three experiments with actinomycin D (5 rPHMs probe includes bp 275-1444 of rPAM-1 and was constructed as described (Eipper et al., 1991) ; g/ml) (Harrold et al., 1991; Zaidi and Malter, 1994) , half-life estimates of 8 to 12 h were obtained; like the Ant3 probe, the rPHMs probe recognizes all forms of rPAM mRNA. To normalize amounts however, cells appeared vacuolized and unhealthy within 20 h, making it impossible to use this drug of PAM mRNA to the total amount of RNA analysed, an S26 riboprobe was utilized; this riboprobe was to estimate the half-life of a long-lived mRNA such as PAM.
prepared from the S26 plasmid described above and protects a 354 nt fragment.
RNase protection assay
Radiolabeled antisense riboprobes were synthesized Results using 50 Ci [ 32 P]-UTP (800 Ci/mmol; Amersham) and an RNA transcription kit (Stratagene). Probes
Abundance of PAM mRNA were treated with DNase 1 for 15 min at 37°C, extracted with phenol/chloroform, ethanol preNorthern blot analysis and biosynthetic labeling experiments both indicated that PAM was a major cipitated by gel electrophoresis or by application to a NucTrap⊂ column (Stratagene) and had specific product in the atrium of neonatal rats and in cultured atrial myocytes (Maltese and Eipper, 1993; activities ranging from 1 to 8×10 8 cpm/ g. Sense riboprobe standards for determining the absolute Braas et al., 1989) . The PAM gene is subject to alternative splicing and PAM-1 and PAM-2 mRNAs level of PAM mRNA were synthesized using an RNA transcription kit (Stratagene); the amount of are the major forms found in the atrium (Fig. 1) . In order to quantify more precisely the total amount riboprobe was quantified by measuring absorbance at 260 nm following phenol/chloroform extraction of PAM mRNA present and to compare PAM expression to ANP expression, we developed an RNase and ethanol precipitation.
Assays were performed using the RPA II kit from protection assay with a probe capable of measuring all forms of PAM mRNA (Fig. 1) . In two independent Ambion (Austin, TX, USA). Briefly, RNA samples (2 to 10 g) were ethanol precipitated with 0.5 to experiments, 1 g RNA prepared from postnatal the contributions of transcription rate and mRNA stability have not yet been investigated. We used two different methods to measure the turnover of PAM mRNA in primary atrial cardiomyocytes (Harrold et al., 1991) . We utilized 5,6-dichloro-1-day 2 rat atrium contained 129±39 pg PAM mRNA; the same amount of postnatal day 2 vent--ribofuranosyl benzimidazole, an adenosine analog which inhibits transcription by RNA polymerase II ricular RNA contained 17.1±6.1 pg PAM mRNA. If we estimate the poly(A+) content of atrial and within an hour after its application to cell cultures. Atrial cultures were exposed to 5,6-dichloro-1--ventricular RNA at 2 to 5% of the total RNA (Harrold et al., 1991) , PAM transcripts account for ribofuranosyl benzimidazole (70 ) for varying periods of time and total RNA was then subjected 0.26 to 0.65% of atrial mRNA and 0.034 to 0.085% of ventricular mRNA. Assuming that each atrial to Northern blot analysis (Fig. 2a) . Data from four independent experiments have been averaged to cardiomyocyte contains approximately 40 pg total RNA (Maltese and Eipper, 1992), each would conyield an estimate of 20±1 h for the half-life of PAM transcripts in primary atrial cardiomyocytes ( Fig.  tain about 2400 molecules of PAM mRNA. Adult atrium contained 8.5-fold more PAM mRNA than 2b). The level of PAM transcript was also measured at various times following treatment of cultures adult ventricle (118±53 v 13.8±7.6 pg PAM mRNA/ g total RNA); when normalized to levels with 5 g/ml actinomycin D (data not shown).
Despite the toxic effects of prolonged exposure to the of S26 mRNA, PAM mRNA levels in adult atrium were approximately double those in postnatal day drug, it was clear in three independent experiments that the half-life of PAM mRNAs was between 8 2 atrium. and 12 h; the PAM message was clearly not turning comparison, proANP mRNA accounts for 1 to 3% of the total mRNA in the atrium (Rosenzweig and over rapidly. Seidman, 1991) . The high levels of PAM found in this tissue in the absence of correspondingly high levels of substrate suggest that PAM might serve a Regulation of PAM mRNA levels different function in the atrium. Although expression of PAM in primary atrial In the heart, as in the pituitary and the hypothalamus, levels of PAM mRNA are subject to horcardiomyocytes can be manipulated by treatment with T 3 or dexamethasone, the system is not a monal regulation (Thiele et al., 1989; Ouafik et al., 1990; Grino et al., 1990) . Glucocorticoids and rapidly responsive one. The half-life of newly synthesized PAM-2 protein was previously shown to thyroid hormone are major hormonal regulators of cardiac tissue and we previously observed a be approximately 8 h in primary cultures of neonatal rat atrium and these studies demonstrate that stimulatory effect of dexamethasone, a synthetic glucocorticoid, on PAM expression in atrial carthe half-life of PAM transcripts is approximately 20 h. Half-lives of different mRNAs can vary from diomyocytes using Northern blot analysis (Thiele et al., 1989) . Glocucorticoids are well known for 20 min to over 24 h (Sachs, 1993) . Levels of PAM mRNA in vivo are subject to fairly rapid regulation their hypertrophic effects on cardiac cells and thyroid hormones have profound effects on heart rate both during development (Ouafik et al., 1989) and in response to electroconvulsive shock (Bhat et al., and myocardial contractility (Shanker et al., 1987; Rohrer and Dillman, 1988; Argentin et al., 1991 Argentin et al., ). 1993 . Between embryonic day 21 and postnatal day 1, total levels of PAM mRNA in the rat atrium Primary atrial cardiomyocytes kept in culture for 6 days were maintained in the absence of either drop three-fold and the splicing pattern is completely altered (Ouafik et al., 1989) . The factors hormone for 48 h and then treated with either dexamethasone or thyroid hormone for 48 h. RNAs responsible for the rapid turnover of PAM transcripts in vivo do not appear to be functional in these from control and treated cultures were examined following Northern blot analysis or RNase proprimary cultures. Thyroid hormones produce a general increase in tection. As shown in Figure 3 , treatment with 100 n or 1  dexamethasone resulted in an total RNA and mRNA levels in the rat heart and have a selective effect on expression of a few mRNA increase in levels of PAM mRNA. Treatment with 10 n or 100 n triiodothyronine reduced levels species including phospholamban, dihydropyridinesensitive slow Ca 2+ channels and sarcolemmal Ca 2+ of PAM mRNA. Similar results were obtained uisng the RNase protection assay (Fig. 4) ; triATPase (Shanker et al., 1987; Rohrer et al., 1991; Seppet et al., 1993; Kimura et al., 1994) . Thyroid iodothyronine treatment reduced levels of PAM mRNA to 66±9% of control (P<0.005) while treathormone-stimulated products in the heart are generally energy consuming enzymes; contraction vement with dexamethasone increased levels of PAM mRNA to 170±20% of control (P<0.005). locity is increased due to a shift in the myosin heavy chain isoform expressed and changes in diastolic relaxation are attributed to alterations in the speed of myocytic Ca 2+ sequestration (Rohrer and Dillman, 1988; Rohrer et al., 1991) . Thyroid hormone treatment of cultured atrial myocytes apHigh level expression of PAM is observed in the atria of several species including rat, bovine and proximately doubles levels of ANP mRNA and ANP secretion (Gardner et al., 1987; Matsubara et al., ovine (Eipper et al., 1988; Braas et al., 1989; Maltese and Eipper, 1992; Lew and Smith, 1993), sug-1987) . Addition of thyroid hormone to primary cultures gesting that the enzyme serves an important function in this tissue. Although several precursors to of neonatal atrial myocytes produces a small decrease in levels of PAM mRNA. PAM mRNA levels -amidated peptides are expressed in the atrium of the heart, the predominant endogenous peptides, in the adult rat anterior pituitary decline more dramatically as thyroid hormone levels rise from ANP and brain natriuretic peptide, are not -amidated and potentially -amidated products are hypothyroid to euthyroid; in contrast, PAM expression in adult male rat atrium was unaffected found at much lower levels. Estimates of PAM prevalence based on metabolic labeling and mRNA by thyroid hormone levels (Ouafik et al., 1990) . The rat PAM promoter is a GC-rich, TATA-less prevalence agree remarkably well; approximately 0.5% of the mRNA and protein synthesis in the promoter lacking any consensus thyroid hormone response elements in the 2000 nucleotides atrium of the neonatal rat is devoted to PAM. In preceding the transcriptional start site (Hand et al., 1991; Greenwald et al., 1992; Sei et al., 1992) . PAM mRNA levels are increased in parallel with 1994); thus the mechanisms responsible for the developmental specific thyroid hormone responses pro-ANP mRNA levels in response to dexamethasone. Like pro-ANP, some of the endogenous observed are not yet clear. Thyroid hormone levels are rising in the perinatal period when the heart is precursors to -amidated peptides identified in the atrium might undergo rapid cleavage and -amidundergoing dramatic developmental changes (Dussault and Ruel, 1987; Strait et al., 1990) and ation coupled to secretion to yield peptides that play an autocrine or paracrine role in the effect PAM expression in both atrium and ventricle declines markedly at birth from peak values of thyroid hormone or glucocorticoids on atrial growth. The PAM promoter lacks a consensus glureached during late embryonic stages.
Discussion
Glucocorticoids acting directly on cardiac tissue cocorticoid response element (Hand et al., 1994) ; however, it contains a putative AP1 site, suggesting have anabolic effects (Argentin et al., 1991) ; cardiac contractility increases and ANP expression and a mechanism through which the glucocorticoid receptor could regulate transcription of the PAM secretion increase (Matsubara et al., 1987) . The processing of pro-ANP to ANP is increased when gene (Yang-Yen et al., 1990; Vig et al., 1994) . Current studies on the determinants of mRNA primary atrial myocytes are maintained in serumfree medium supplemented with dexamethasone stability suggest that mRNAs are inherently stable; the rapid turnover observed for certain transcripts (Glembotski et al., 1990; Rosenzweig and Seidman, (Cleveland and Yen, 1989; Sachs, 1993) 
